Pfizer Submits Data to FDA for COVID-19 Vaccine in Younger Children

Pfizer Submits Data to FDA for COVID-19 Vaccine in Younger Children

Newsmax

Published

Pfizer Inc and BioNTech SE submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 to U.S. regulators on Tuesday and said they would make a formal request for emergency use authorization in the coming weeks. Coronavirus infections have soared in...

Full Article